Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 2012. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons under the GlaxoSmithKline 2009 Deferred Annual Bonus Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share acquisition details related to a deferred bonus plan.
- Share Price: 1408.5 pence per Ordinary Share and $44.97 per ADS.
- Transaction Date: April 16, 2012 (notification date) following dividend reinvestment on April 12, 2012.
Material Changes
The filing details an increase in notional interests in Ordinary Shares and American Depositary Shares (ADSs) for several executives. These acquisitions resulted from the re-investment of dividends paid to shareholders. Specific acquisitions include:
- Sir Andrew Witty: Acquired 1099 Ordinary Shares (personal contribution) and 1099 Ordinary Shares (company matching contribution).
- Mr S M Bicknell: Acquired 129 Ordinary Shares (personal) and 129 Ordinary Shares (company match).
- Mr D S Redfern: Acquired 71 ADSs (personal) and 71 ADSs (company match).
- Dr M M Slaoui: Acquired 145 Ordinary Shares (personal) and 145 Ordinary Shares (company match).
- Ms C Thomas: Acquired 355 ADSs (personal) and 355 ADSs (company match).
- Mr D E Troy: Acquired 32 Ordinary Shares (personal) and 32 Ordinary Shares (company match).
- Dr P J T Vallance: Acquired 178 ADSs (personal) and 178 ADSs (company match).
- Mrs D P Connelly: Acquired 288 Ordinary Shares (personal) and 288 Ordinary Shares (company match).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, or contingencies. It notes that notional dividends accrued will be paid out in proportion to the percentage of the participant's deferred annual bonus holdings that vest following the end of the relevant three-year measurement period.
Investor Verification Checklist
- Verify the vesting schedule and conditions for the 2009 Deferred Annual Bonus Plan.
- Confirm the total number of shares held by each executive following these transactions.
- Review the company's broader dividend policy and reinvestment mechanisms.
- Check for any subsequent filings regarding the vesting of these deferred bonuses.